326 related articles for article (PubMed ID: 34715852)
1. How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions.
Eder P; Zielińska A; Karczewski J; Dobrowolska A; Słomski R; Souto EB
J Nanobiotechnology; 2021 Oct; 19(1):346. PubMed ID: 34715852
[TBL] [Abstract][Full Text] [Related]
2. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
[TBL] [Abstract][Full Text] [Related]
4. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
Wang Y; Wang J; Pekow J; Dalal S; Cohen RD; Ollech J; Israel A; Shogan BD; Micic D; Cannon L; Umanskiy K; Hurst R; Hyman N; Rubin DT; Sakuraba A
J Gastroenterol Hepatol; 2019 Dec; 34(12):2090-2095. PubMed ID: 31169926
[TBL] [Abstract][Full Text] [Related]
5. Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients.
Cha JM; Park DI; Park SH; Shin JE; Kim WS; Yang SK
J Korean Med Sci; 2017 Jan; 32(1):85-94. PubMed ID: 27914136
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease.
Li X; Yu M; Zhu Z; Lu C; Jin M; Rao Y; Zhao Q; Lu X; Yu C
Carbohydr Polym; 2021 Dec; 273():118556. PubMed ID: 34560967
[TBL] [Abstract][Full Text] [Related]
7. Reversal of anti-drug antibodies against tumor necrosis factor inhibitors with addition of immunomodulators: A systematic review and meta-analysis.
Dhindsa BS; Dhaliwal A; Mashiana HS; Saghir SM; Sayles H; Mubder M; Ohning G; Eichele D
Indian J Gastroenterol; 2020 Apr; 39(2):153-160. PubMed ID: 32468382
[TBL] [Abstract][Full Text] [Related]
8. AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease.
Bhol KC; Tracey DE; Lemos BR; Lyng GD; Erlich EC; Keane DM; Quesenberry MS; Holdorf AD; Schlehuber LD; Clark SA; Fox BS
Inflamm Bowel Dis; 2013 Oct; 19(11):2273-81. PubMed ID: 23949620
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease.
Nakase H
Gut Liver; 2020 Jan; 14(1):7-19. PubMed ID: 30919602
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.
Mitoma H; Horiuchi T; Tsukamoto H; Ueda N
Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553
[TBL] [Abstract][Full Text] [Related]
11. Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.
Pouillon L; Bossuyt P; Peyrin-Biroulet L
Expert Opin Biol Ther; 2016 Oct; 16(10):1277-90. PubMed ID: 27329436
[TBL] [Abstract][Full Text] [Related]
12. Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies.
Bendtzen K; Ainsworth M; Steenholdt C; Thomsen OØ; Brynskov J
Scand J Gastroenterol; 2009; 44(7):774-81. PubMed ID: 19140087
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor Necrosis Factor-alpha Exposure Impacts Vedolizumab Mucosal Healing Rates in Pediatric Inflammatory Bowel Disease.
Jossen J; Kiernan BD; Pittman N; Dubinsky MC
J Pediatr Gastroenterol Nutr; 2020 Mar; 70(3):304-309. PubMed ID: 31738290
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF therapy in inflammatory bowel diseases: a huge review.
Peyrin-Biroulet L
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):233-43. PubMed ID: 20485259
[TBL] [Abstract][Full Text] [Related]
15. Update on the mechanisms of action of anti‑TNF-α antibodies and their clinical implications in inflammatory bowel disease.
Eder P; Linke K; Witowski J
Pol Arch Med Wewn; 2016 Sep; 126(10):772-780. PubMed ID: 27872451
[TBL] [Abstract][Full Text] [Related]
16. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
17. Rectal delivery of
Fan Y; Wang X; Yan G; Gao H; Yang M
J Mater Chem B; 2023 Dec; 11(47):11228-11234. PubMed ID: 37990919
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease and targeted oral anti-TNFα therapy.
Griffiths OR; Landon J; Coxon RE; Morris K; James P; Adams R
Adv Protein Chem Struct Biol; 2020; 119():157-198. PubMed ID: 31997768
[TBL] [Abstract][Full Text] [Related]
19. Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).
Porcari S; Viola A; Orlando A; Privitera AC; Ferracane C; Cappello M; Vitello A; Siringo S; Inserra G; Magnano A; Mocciaro F; Di Mitri R; Belluardo N; Fidanza O; Garufi S; Magrì G; Bertolami C; Carroccio A; Macaluso FS; Renna S; Ventimiglia M; Alibrandi A; Cottone M; Fries W;
Drugs Aging; 2020 May; 37(5):383-392. PubMed ID: 32016824
[TBL] [Abstract][Full Text] [Related]
20. Optimizing anti-TNF treatments in inflammatory bowel disease.
Ben-Horin S; Kopylov U; Chowers Y
Autoimmun Rev; 2014 Jan; 13(1):24-30. PubMed ID: 23792214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
